NexScreen provides point-of-care diagnostic testing solutions to customers across the United States, Australia and New Zealand. TransMed offers a broad catalog of drug testing products and laboratory ...

Align Capital Partners’ (“ACP”) drug and alcohol testing solutions provider Premier Biotech (“Premier” or the “Company”) has acquired GH Solutions (“GH”), a distributor of point-of-care diagnostic ...

NTS serves over 1,500 facilities throughout the US, primarily in government and behavioral health end markets NTS CEO Andrew Panico will remain involved with the company to support continued growth ...

Desert Tox’s founders, Mike Grommes and Mike Gorman, will remain involved with the company Desert Tox marks Premier’s first add-on since ACP’s acquisition of the company in November 2022 Based in ...

Align Capital Partners’ (“ACP”) toxicology testing solutions provider Premier Biotech (“Premier” or the “Company”) completed two successive acquisitions including OraSure Technologies, Inc.’s (“OTI”) ...

Align Capital Partners’ (“ACP”) drug and alcohol testing solutions provider, Premier Biotech (“Premier” or the “Company”), announced the acquisitions of NexScreen and TransMed. These strategic ...

Align Capital Partners’ ("ACP") drug and alcohol testing solutions provider, Premier Biotech ("Premier" or the "Company"), announced the acquisitions of NexScreen and TransMed. These strategic ...